Skip to main content

Search

9 result(s) for 'author#Margitta Retz' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Authors: Sven D Koch, Henoch Hong, Susan Feyerabend, Margitta Retz, Hubert Kuebler, Axel Heidenreich, Thomas van Erps, Andreas Schroeder, Birgit Scheel, Valérie Reus, Karl-Josef Kallen, Mariola Fotin-Mleczek, Ulrike Gnad-Vogt and Arnulf Stenzl
    Citation: Journal for ImmunoTherapy of Cancer 2014 2(Suppl 3):P85
    Content type: Poster presentation Published on:

    This article is part of a Supplement: Volume 2 Supplement 3

  2. Patients with locally advanced and high-risk prostate cancer (LAPC) are prone to experience biochemical recurrence despite radical prostatectomy (RP). We evaluated feasibility, safety and activity of a neoadju...

    Authors: Mark Thalgott, Thomas Horn, Matthias M Heck, Tobias Maurer, Matthias Eiber, Margitta Retz, Michael Autenrieth, Kathleen Herkommer, Bernd J Krause, Jürgen E Gschwend, Uwe Treiber and Hubert R Kübler
    Citation: Journal of Hematology & Oncology 2014 7:20
    Content type: Research Published on:

  3. This study evaluated the cytotoxic and antiproliferative efficacy of two well-characterized members of the Cecropin-family of antimicrobial peptides against bladder tumor cells and benign fibroblasts.

    Authors: Henrik Suttmann, Margitta Retz, Friedrich Paulsen, Jürgen Harder, Ulrike Zwergel, Jörn Kamradt, Bernd Wullich, Gerhard Unteregger, Michael Stöckle and Jan Lehmann
    Citation: BMC Urology 2008 8:5
    Content type: Research article Published on:

  4. Vinflunine is recommended in the European guideline for the treatment of advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based therapy.

    Authors: Margitta Retz, Patrick de Geeter, Peter J. Goebell, Ullrich Matz, Wito de Schultz and Axel Hegele
    Citation: BMC Cancer 2015 15:455
    Content type: Research article Published on:

  5. Constitutive expression and localization of antimicrobial human β-defensin-1 (HBD-1) in human kidneys as a potential mechanism of antimicrobial defense has been previously reported. Inducible expression of hum...

    Authors: Jan Lehmann, Margitta Retz, Jürgen Harder, Matthias Krams, Udo Kellner, Julia Hartmann, Kerstin Hohgräwe, Uta Raffenberg, Martin Gerber, Tillmann Loch, Klaus Weichert-Jacobsen and Michael Stöckle
    Citation: BMC Infectious Diseases 2002 2:20
    Content type: Research article Published on:

  6. Previous investigations on the association of human papillomavirus (HPV) and human bladder cancer have led to conflicting results. The aim of this study was to determine if low and high risk HPV play a role in...

    Authors: Sebastian C. Schmid, Leonore Thümer, Tibor Schuster, Thomas Horn, Florian Kurtz, Julia Slotta-Huspenina, Judith Seebach, Michael Straub, Tobias Maurer, Michael Autenrieth, Hubert Kübler, Margitta Retz, Ulrike Protzer, Jürgen E. Gschwend and Dieter Hoffmann
    Citation: Infectious Agents and Cancer 2015 10:31
    Content type: Research Article Published on:

  7. Circulating tumor cell (CTCs) counts might serve as early surrogate marker for treatment efficacy in metastatic castration-resistant prostate cancer (mCRPC) patients. We prospectively assessed categorical and ...

    Authors: Mark Thalgott, Brigitte Rack, Matthias Eiber, Michael Souvatzoglou, Matthias M. Heck, Caroline Kronester, Ulrich Andergassen, Victoria Kehl, Bernd J. Krause, Jurgen E. Gschwend, Margitta Retz and Roman Nawroth
    Citation: BMC Cancer 2015 15:458
    Content type: Research article Published on:

  8. Castration-resistant prostate cancer (CRPC) is associated with wide variations in survival. Recent studies of whole blood mRNA expression-based biomarkers strongly predicted survival but the genes used in thes...

    Authors: Li Wang, Yixuan Gong, Uma Chippada-Venkata, Matthias Michael Heck, Margitta Retz, Roman Nawroth, Matthew Galsky, Che-Kai Tsao, Eric Schadt, Johann de Bono, David Olmos, Jun Zhu and William K. Oh
    Citation: BMC Medicine 2015 13:201
    Content type: Research article Published on:

  9. Patients with locally advanced bladder cancer (cT3/4 cN0/N+ cM0) have a poor prognosis despite radical surgical therapy and perioperative chemotherapy. Preliminary data suggest that the combination of radiatio...

    Authors: Sebastian C. Schmid, Florestan J. Koll, Claus Rödel, Philipp Maisch, Andreas Sauter, Franziska Beckert, Anna Seitz, Hubert Kübler, Michael Flentje, Felix Chun, Stephanie E. Combs, Kilian Schiller, Jürgen E. Gschwend and Margitta Retz
    Citation: BMC Cancer 2020 20:8
    Content type: Study protocol Published on: